NASDAQ:CRNX
Crinetics Pharmaceuticals Inc Stock News
$51.40
-0.510 (-0.98%)
At Close: May 17, 2024
Cubist Systematic Strategies LLC Buys 2,922 Shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX)
09:06am, Saturday, 18'th Apr 2020
Cubist Systematic Strategies LLC grew its stake in shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) by 164.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 4,700 shares of the
Crinetics Pharmaceuticals, Inc. (CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocr
SAN DIEGO, April 17, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the...
Crinetics Pharmaceuticals, Inc. (CRNX) Upgraded to Buy: Here's What You Should Know
04:00pm, Friday, 17'th Apr 2020
Crinetics Pharmaceuticals, Inc. (CRNX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near ter
Crinetics Pharmaceuticals, Inc. (CRNX) Upgraded to Buy: Here's What You Should Know
04:00pm, Friday, 17'th Apr 2020
Crinetics Pharmaceuticals, Inc. (CRNX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term
The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US
12:03pm, Wednesday, 15'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs April 14) * Bio-Rad Laboratories, Inc. (NYSE: BIO) * Accelero
BRIEF-Crinetics Pharmaceuticals Prices Public Offering Of 7.15 Mln Common Stock
04:25am, Wednesday, 15'th Apr 2020
Crinetics Pharmaceuticals Inc:
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
04:22am, Wednesday, 15'th Apr 2020
Crinetics Pharmaceuticals, Inc. (CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocr
BRIEF-Crinetics Pharmaceuticals Announces Proposed Public Offering Of Common Stock
08:29pm, Tuesday, 14'th Apr 2020
Crinetics Pharmaceuticals Inc:
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
08:05pm, Tuesday, 14'th Apr 2020
Crinetics Pharmaceuticals, Inc. (CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocr
Daily Insider Ratings Round Up 4/7/20
01:56pm, Thursday, 09'th Apr 2020
Tables of the top insider purchases and sales filed with the SEC on 4/7/20, based on dollar value. Dollar values often do not equate with significance when it c
Mesoblast's COVID-19 Foray, And Other News: The Good, Bad And Ugly Of Biopharma
09:16pm, Wednesday, 08'th Apr 2020
Mesoblast was up on an IND approval targeting COVID-19. Crinetics announced positive trial data. Bellerophon announced earnings and program updates.
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) Major Shareholder Vivo Capital Viii, Llc Sells 6,115 Shares
11:02am, Wednesday, 08'th Apr 2020
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) major shareholder Vivo Capital Viii, Llc sold 6,115 shares of the company’s stock in a transaction dated Tuesday, April 7th. The stock was sold at an aver
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) Major Shareholder Vivo Capital Viii, Llc Sells 300,000 Shares
09:26am, Wednesday, 08'th Apr 2020
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) major shareholder Vivo Capital Viii, Llc sold 300,000 shares of the company’s stock in a transaction on Friday, April 3rd. The stock was sold at an averag
H.C. Wainwright Thinks Crinetics Pharmaceuticals’ Stock is Going to Recover
06:21am, Wednesday, 08'th Apr 2020
In a report released yesterday, Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Crinetics Pharmaceuticals (CRNX – Research
